Daily news and information for physicians in a range of specialties and practice settings.
How alirocumab fared for patients with polyvascular disease in a subset of the major clinical trial.
Heart disease is the greatest cause of death in women, and Wood believes female patients would better from a multidisciplinary approach.
Among participants of the EMPA-REG OUTCOME trial who experienced heart failure, empagliflozin was associated with lower rates of short-term re-hospitalization and death.
How an antibiotic envelope can address concerns of infection in cardiovascular devices.
A new study of a blood pressure-monitoring mobile app reports patients with diabetes could reach better thresholds.
Flu tracking estimates that don’t consider behavioral differences between different demographic groups will tend to underestimate the spread of the flu, a new study reports.
What do some of the findings from one of the biggest presentations at ACC mean for the state of valve replacement care?
Why every care provider must be able to prepare for and commit to an "emergency protocol" in the face of adversity.
A 5000-plus patient study found that about 80% of young women have never been administered a lipid test.
The rate of heart attacks among patients under 40 years old has been increasing by 2% annually for the past decade.
Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.